Inhaltsbereich
| 853 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 43
 Druckansicht
|
| Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial. |
| von Minckwitz G, Puglisi F, Cortes J, Vrdoljak E, Marschner N, Zielinski C, Villanueva C, Romieu G, Lang I, Ciruelos E, De Laurentiis M, Veyret C, de Ducla S, Freudensprung U, Srock S, Gligorov J |
| The Lancet. Oncology. 2014 Sep 28. pii: S1470-2045(14)70439-5. doi: 10.1016/S1470-2045(14)70439-5 |
| PMID: 25273342 |
| Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses. |
| Brodowicz T, Lang I, Kahan Z, Greil R, Beslija S, Stemmer SM, Kaufman B, Petruzelka L, Eniu A, Anghel R, Koynov K, Vrbanec D, Pienkowski T, Melichar B, Spanik S, Ahlers S, Messinger D, Inbar MJ, Zielinski C |
| British journal of cancer. 2014 Sep 30. pii: bjc2014504. doi: 10.1038/bjc.2014.504. pmc: PMC4260030 |
| PMID: 25268370 |
| Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. |
| Schukro C, Syeda B, Kirisits C, Schmid R, Pichler P, Pokrajac B, Lang I, Pötter R, Glogar D |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2006 Sep 12. pii: S0167-8140(06)00396-3. doi: 10.1016/j.radonc.2006.08.016 |
| PMID: 16971011 |
| Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients. |
| Syeda B, Schukro C, Kirisits C, Lang I, Siostrzonek P, Gottsauner-Wolf M, Pokrajac B, Schmid R, Yahya N, Pötter R, Glogar D |
| Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2005 Nov 22. pii: S0167-8140(05)00474-3. doi: 10.1016/j.radonc.2005.10.012 |
| PMID: 16309769 |
| Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. |
| Weninger W, Uthman A, Pammer J, Pichler A, Ballaun C, Lang IM, Plettenberg A, Bankl HC, Stürzl M, Tschachler E |
| Laboratory investigation; a journal of technical methods and pathology. 1996 Dec 30. |
| PMID: 8941211 |
| Predictive role of hand-foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer. |
| Zielinski C, Lang I, Beslija S, Kahan Z, Inbar MJ, Stemmer SM, Anghel R, Vrbanec D, Messinger D, Brodowicz T |
| British journal of cancer. 2015 Dec 10. pii: bjc2015419. doi: 10.1038/bjc.2015.419 |
| PMID: 26657657 |
| Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers. |
| Hobl EL, Reiter B, Schoergenhofer C, Schwameis M, Derhaschnig U, Lang IM, Stimpfl T, Jilma B |
| Clinical research in cardiology : official journal of the German Cardiac Society. 2015 Oct 22. doi: 10.1007/s00392-015-0927-z. pii: 10.1007/s00392-015-0927-z |
| PMID: 26493304 |
| Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial. |
| Thallinger C, Lang I, Kuhar CG, Bartsch R, Singer CF, Petruzelka L, Melichar B, Knittelfelder R, Brodowicz T, Zielinski C |
| BMC cancer. 2016 Feb 18. doi: 10.1186/s12885-016-2171-y. pii: 10.1186/s12885-016-2171-y |
| PMID: 26887956 |
| Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. |
| Englinger B, Lötsch D, Pirker C, Mohr T, van Schoonhoven S, Boidol B, Lardeau CH, Spitzwieser M, Szabó P, Heffeter P, Lang I, Cichna-Markl M, Grasl-Kraupp B, Marian B, Grusch M, Kubicek S, Szakács G, Berger W |
| Oncotarget. 2016 Jun 29. pii: 10324. doi: 10.18632/oncotarget.10324 |
| PMID: 27367030 |
| Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial. |
| Zielinski C, Láng I, Inbar M, Kahán Z, Greil R, Beslija S, Stemmer SM, Zvirbule Z, Steger GG, Melichar B, Pienkowski T, Sirbu D, Petruzelka L, Eniu A, Nisenbaum B, Dank M, Anghel R, Messinger D, Brodowicz T |
| The Lancet. Oncology. 2016 Aug 5. pii: S1470-2045(16)30154-1. doi: 10.1016/S1470-2045(16)30154-1 |
| PMID: 27501767 |
| Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. |
| Peters S, Stahel RA, Dafni U, Aix SP, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Noguera JG, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AM, Vidal ÓJ, Sanchez RP, Villa Guzmán JC, Martin RC, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJ, van den Berg PM, Zielinski CC, Kuruvilla YC, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF |
| Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 Dec 22. pii: S1556-0864(16)33607-3. doi: 10.1016/j.jtho.2016.12.017 |
| PMID: 28017787 |
| Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial. |
| Rao MP, Al-Khatib SM, Pokorney S, She L, Romanov A, Nicolau JC, Lee KL, Carson PE, Selzman CH, Stepinska J, Cleland JG, Tungsubutra W, Desvigne-Nickens PM, Sueta C, Siepe M, Lang IM, Feldman AM, Yii M, Rouleau JL, Velazquez EJ |
| Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075. doi: 10.1161/CIRCULATIONAHA.116.026075 |
| PMID: 28154006 |
| 409TiPPHASE III STUDY OF PALBOCICLIB IN COMBINATION WITH EXEMESTANE VS. CAPECITABINE, IN HORMONAL RECEPTOR (HR) POSITIVE/HER2 NEGATIVE METASTATIC BREAST CANCER (MBC) PATIENTS WITH RESISTANCE TO NON-STEROIDAL AROMATASE INHIBITORS (NSAI): PEARL STUDY (GEICAM/2013-02_CECOG/BC.1.3.006). |
| Martin M, Beslija S, Carrasco E, Kahan Z, Escudero MJ, Láng I, Bartlett CH, Bermejo B, Inbar M, Chacón JI, Jinga DC, García-Sáenz JA, Haba J, Koehler M, Morales S, Gil JM, Antón A, Ruiz-Borrego M, Murillo L, Zielinski C |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241157. doi: 10.1093/annonc/mdu329.59 |
| PMID: 28172063 |
| 353OEFFICACY AND SAFETY IN TANIA, A RANDOMISED PHASE III TRIAL OF CONTINUED OR REINTRODUCED BEVACIZUMAB (BEV) AFTER 1ST-LINE BEV FOR HER2-NEGATIVE LOCALLY RECURRENT/METASTATIC BREAST CANCER (LR/MBC). |
| von Minckwitz G, Puglisi F, Cortes J, Vrdoljak E, Marschner N, Zielinski C, Villanueva CB, Romieu G, Láng I, Ciruelos E, De Laurentiis M, Veyret C, De Ducla S, Freudensprung U, Srock S, Gligorov J |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241122. doi: 10.1093/annonc/mdu329.3 |
| PMID: 28171246 |
| The VKORC1 polymorphism rs9923231 is associated with aneurysms of the ascending aorta in an Austrian population. |
| Andreas M, Panzenboeck A, Shabanian S, Kocher A, Mannhalter C, Petzl A, Hueblauer J, Wolzt M, Ehrlich M, Lang I |
| Thrombosis research. 2017 Feb 14. pii: S0049-3848(17)30033-6. doi: 10.1016/j.thromres.2017.02.009 |
| PMID: 28222321 |
| Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure. |
| Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Lang I, Wojta J, Hülsmann M, Niessner A |
| Journal of clinical lipidology. 2016 Dec 7. pii: S1933-2874(16)30447-0. doi: 10.1016/j.jacl.2016.11.009 |
| PMID: 28391884 |
| Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. |
| Bonderman D, Pretsch I, Steringer-Mascherbauer R, Jansa P, Rosenkranz S, Tufaro C, Bojic A, Lam CSP, Frey R, Ochan Kilama M, Unger S, Roessig L, Lang IM |
| Chest. 2014 Nov 4. pii: S0012-3692(15)52395-7. doi: 10.1378/chest.14-0106. pmc: PMC4219342 |
| PMID: 24991733 |
| Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. |
| Moser B, Jaksch P, Taghavi S, Muraközy G, Lang G, Hager H, Krenn C, Roth G, Faybik P, Bacher A, Aigner C, Matilla JR, Hoetzenecker K, Hacker P, Lang I, Klepetko W |
| European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2017 Jul 27. pii: 4049554. doi: 10.1093/ejcts/ezx212 |
| PMID: 28950326 |
| Normal values for Doppler echocardiographic assessment of prosthetic valve function after transcatheter aortic valve replacement: a systematic review and meta-analysis. |
| Winter MP, Zbiral M, Kietaibl A, Sulzgruber P, Kastner J, Rosenhek R, Binder T, Lang IM, Goliasch G |
| European heart journal cardiovascular Imaging. 2017 Sep 6. pii: 4106330. doi: 10.1093/ehjci/jex212 |
| PMID: 28950312 |
| Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. |
| Goliasch G, Bartko PE, Pavo N, Neuhold S, Wurm R, Mascherbauer J, Lang IM, Strunk G, Hülsmann M |
| European heart journal. 2017 Jul 25. pii: 4035734. doi: 10.1093/eurheartj/ehx402 |
| PMID: 29020337 |
| 853 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 › » |
Seite 1 / 43
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
